These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 3882763)

  • 21. Selective conversion from azathioprine to cyclosporin for steroid-resistant rejection in renal transplants: an alternative therapy.
    Crowson MC; Berisa F; McGonigle RJ; Adu D; Michael J; Barnes AD
    Nephrol Dial Transplant; 1989; 4(2):129-32. PubMed ID: 2496354
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Haemolytic-uraemic syndrome in recipients of bone marrow transplants not treated with cyclosporin A.
    Marshall RJ; Sweny P
    Histopathology; 1986 Sep; 10(9):953-62. PubMed ID: 3536715
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hyperkalaemia in cyclosporin-treated renal allograft recipients.
    Adu D; Turney J; Michael J; McMaster P
    Lancet; 1983 Aug; 2(8346):370-2. PubMed ID: 6135874
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Thrombotic microangiopathy in the early post-renal transplant period.
    Ardalan MR; Shoja MM; Tubbs RS; Etemadi J; Esmaili H; Khosroshahi HT
    Ren Fail; 2008; 30(2):199-203. PubMed ID: 18300121
    [TBL] [Abstract][Full Text] [Related]  

  • 25. De novo hemolytic uremic syndrome in renal transplant recipients immunosuppressed with cyclosporine.
    Van Buren D; Van Buren CT; Flechner SM; Maddox AM; Verani R; Kahan BD
    Surgery; 1985 Jul; 98(1):54-62. PubMed ID: 3892747
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Renal lesions induced by cyclosporin. Apropos of 4 renal biopsies and 22 necropsies of recipients of heart transplant].
    Chomette G; Auriol M; Beaufils H; Rottembourg A; Cabrol C
    Ann Pathol; 1986; 6(1):29-36. PubMed ID: 3521626
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Kidney pathology in liver allograft recipients after long-term treatment with cyclosporin A.
    Dische FE; Neuberger J; Keating J; Parsons V; Calne RY; Williams R
    Lab Invest; 1988 Apr; 58(4):395-402. PubMed ID: 3282124
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Blood cyclosporin concentrations and renal allograft dysfunction.
    Holt DW; Marsden JT; Johnston A; Bewick M; Taube DH
    Br Med J (Clin Res Ed); 1986 Oct; 293(6554):1057-9. PubMed ID: 3094774
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hypertension after renal transplantation in patients treated with cyclosporin and azathioprine.
    Gordjani N; Offner G; Hoyer PF; Brodehl J
    Arch Dis Child; 1990 Mar; 65(3):275-9. PubMed ID: 2334203
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The influence of cyclosporin on graft and patient survival after renal transplantation. The Groote Schuur Hospital experience.
    Jacobson JE; Swanepoel CR; Pontin AR; Pascoe MD; Cassidy MJ; van Zyl Smit R
    S Afr Med J; 1985 Feb; 67(5):166-8. PubMed ID: 3885431
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Platelet CD61 expression in vascular calcineurin inhibitor toxicity of renal allografts.
    Meehan SM; Baliga R; Poduval R; Chang A; Kadambi PV
    Hum Pathol; 2008 Apr; 39(4):550-6. PubMed ID: 18234279
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The presence and prognostic importance of glomerular macrophage infiltration in renal allografts.
    Ozdemir BH; Demirhan B; Güngen Y
    Nephron; 2002 Apr; 90(4):442-6. PubMed ID: 11961403
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Complement factor H deficiency in acute allograft glomerulopathy and post-transplant hemolytic uremic syndrome.
    Fortin MC; Schürch W; Cardinal H; Hébert MJ
    Am J Transplant; 2004 Feb; 4(2):270-3. PubMed ID: 14974950
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Glomerular rejection in kidney allografts under cyclosporin.
    Onitsuka S; Yamaguchi Y; Toma H; Yagisawa T; Takahashi K; Teraoka S; Ota K
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1680-2. PubMed ID: 2652550
    [No Abstract]   [Full Text] [Related]  

  • 35. Severe glomerular fibrin thrombosis in a dog.
    Yabuki A; Ando T; Tanabe M; Kurahara N; Yamato O
    J Vet Med Sci; 2024 Jan; 86(1):87-91. PubMed ID: 38057079
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bone repair in cyclosporin treated renal transplant patients.
    Wilmink JM; Bras J; Surachno S; van Heyst JL; van der Horst JM
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1492-4. PubMed ID: 2652480
    [No Abstract]   [Full Text] [Related]  

  • 37. Immunosuppression by Cyclosporin A in human renal transplant recipients.
    Ringdén O; Bergstrand A; Collste H; Grimfors G; Lundgren G; Groth CG
    Scand J Urol Nephrol Suppl; 1981; 64():220-9. PubMed ID: 6755683
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Histopathological changes in cyclosporin-treated renal allografts biopsied at one and twelve months.
    Bignardi L; Neild GH; Hartley RB; Taube DH; Cameron JS; Rudge CJ; Williams DG; Ogg CS
    Nephrol Dial Transplant; 1987; 2(5):366-70. PubMed ID: 3122115
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characteristic morphological changes in anti-VEGF therapy-induced glomerular microangiopathy.
    Pfister F; Amann K; Daniel C; Klewer M; Büttner A; Büttner-Herold M
    Histopathology; 2018 Dec; 73(6):990-1001. PubMed ID: 30014486
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of pulsatile perfusion with tissue plasminogen activator in deceased donor kidneys with extensive glomerular thrombosis.
    Nghiem DD; Olson PR; Sureshkumar KK
    Transplant Proc; 2009; 41(1):29-31. PubMed ID: 19249467
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.